Fitzgerald Joseph Michael's Form 4 filing
Boston Scientific Corp (BSX) · filed Feb 13, 2025
- Accession no.
- 0001225208-25-001683
- Filed
- Feb 13, 2025
- Trade date
- Dec 3, 2024-Feb 11, 2025
- Filing delay
- 72 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 4 non-derivative transactions. Open-market purchases total $4.51K. Open-market sales total $1.80K. It was filed 72 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Fitzgerald Joseph MichaelCIK 0001484186 | Officer (EVP & Group Pres, Cardiology) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 3, 2024 | Common Stock | PPurchaseAcquired | +50 | $90.29 | +$4,514.5 | 148,168 | Direct | |
| Dec 10, 2024 | Common Stock | SSaleDisposed | −20 | $89.97 | −$1,799.4 | 148,148 | Direct | |
| Feb 11, 2025 | Common Stock | AGrant or awardAcquired | +31,680 | $0.00 | $0 | 187,310 | Direct | |
| Feb 11, 2025 | Common Stock | FTax withholdingDisposed | −14,447 | $105.98 | −$1,531,093.06 | 172,863 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.